Management of anorexia-cachexia associated with cancer and HIV infection.
The cachexia associated with cancer and AIDS appears to result from a number of processes, most of which impair caloric intake. Although past attempts to reverse anorexia-cachexia have generally been disappointing, several promising new pharmacologic approaches are currently being evaluated, including megestrol acetate, hydrazine sulfate, metoclopramide, and dronabinol.
Gorter
R
R
Division of AIDS Oncology, University of California School of Medicine, San Francisco.
D000855:Anorexia / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002100:Cachexia / Q000188:drug therapy*; D013759:Dronabinol / Q000627:therapeutic use; D015658:HIV Infections / Q000503:physiopathology*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008535:Megestrol / Q000031:analogs & derivatives / Q000627:therapeutic use; D019290:Megestrol Acetate; D008787:Metoclopramide / Q000627:therapeutic use; D009369:Neoplasms / Q000503:physiopathology*; D010166:Palliative Care / Q000379:methods
D000970:Antineoplastic Agents; D006834:Hydrazines; C029424:hydrazine; D013759:Dronabinol; D008535:Megestrol; D008787:Metoclopramide; D019290:Megestrol Acetate